Financial News
Biogen Idec (NQ: BIIB )
205.00
+1.68
(+0.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Biogen Idec
![](https://cdn.benzinga.com/files/images/story/2022/12/23/roche.png?width=1200&height=800&fit=crop)
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/713443/businessman-with-a-chart-looking-at-his-computer.jpg)
![](https://g.foolcdn.com/editorial/images/714017/gettyimages-scientist_computer_others-in-background.jpg)
1 Green Flag and 1 Red Flag for Biogen
December 23, 2022
Via The Motley Fool
![](https://cdn.benzinga.com/files/images/story/2022/12/22/biib_logo_light__74da60da9d9119bf81bd30b84737bd7a.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/713567/doctor-holding-elderly-patients-hand.jpg)
![](https://g.foolcdn.com/editorial/images/711590/team-of-scientists-work-in-lab.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/crwd-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600.jpg)
![](https://g.foolcdn.com/editorial/images/713427/gettyimages-1172040755.jpg)
![](https://g.foolcdn.com/editorial/images/712975/gettyimages-1079127056.jpg)
![](https://g.foolcdn.com/editorial/images/711919/doctor-scientist-microscope-gloves-mask-1.jpg)
![](https://g.foolcdn.com/editorial/images/711510/doctor-meeting-a-salesperson.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/lly_eli_lilly_1600.png)
26 Analysts Have This to Say About Biogen
November 30, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/711240/physician-giving-medicine-to-elderly-patient.jpg)
![](https://www.investors.com/wp-content/uploads/2020/06/Stock-bullbearweight-02-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/biogen.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/06/biogen-biib.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/aapharma_11.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/lab-gb20965722_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/image-google-alphabet.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/10/stock-biogen-02-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2548.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/10/stock-biogen-03-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/28/biogen.png?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2016/05/06/16/02/stock-exchange-1376104__480.jpg)
![](https://g.foolcdn.com/editorial/images/710723/smart-investor-having-a-good-day-getty.jpg)
![](https://public.newsdirect.com/371254297/mZYVVPZ6.png)
CBOE's Weekly Market Recap: Nov.14-18 – Biogen’s Alzheimer’s Drug Captures Investors’ Attention
November 23, 2022
Via News Direct
Exposures
Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.